ストックスクリーナーアプリを入手
1.60
3.03%
-0.05
アフターアワーズ：
1.55
-0.05
-3.13%
前日終値:
$1.65
開ける：
$1.54
24時間の取引高:
960.57K
Relative Volume:
0.20
時価総額：
$51.65M
収益：
-
当期純損益:
$-16.14M
株価収益率:
-2.963
EPS:
-0.54
ネットキャッシュフロー:
$-3.99M
1週間 パフォーマンス:
+12.68%
1か月 パフォーマンス:
+17.65%
6か月 パフォーマンス:
-40.52%
1年 パフォーマンス:
-68.44%
1日の値動き範囲:
$1.53
$1.65
1週間の範囲:
$1.53
$2.091
52週間の値動き範囲:
$1.12
$7.0791
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
TELO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.60 | 55.82M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-21 | 開始されました | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc (TELO) 最新ニュース
Does Telomir Pharmaceuticals Inc. show high probability of reboundEarnings Beat & Free Community Consensus Stock Picks - newser.com
What to do if you’re stuck in Telomir Pharmaceuticals Inc.Weekly Earnings Recap & Low Volatility Stock Suggestions - newser.com
Tools to assess Telomir Pharmaceuticals Inc.’s risk profileWeekly Investment Report & Fast Moving Trade Plans - newser.com
Telomir Pharmaceuticals Inc. stock outlook for YEARWeekly Profit Report & Community Driven Trade Alerts - newser.com
Why Telomir Pharmaceuticals Inc. is moving todayMarket Rally & Free Community Supported Trade Ideas - newser.com
Telomir Pharmaceuticals Inc Stock Analysis and ForecastLong-Term Investment Plans & Download Our Free Trading Blueprint - earlytimes.in
What drives Telomir Pharmaceuticals Inc stock priceIndustrial Stocks Review & Free Transform Portfolio With Stocks - earlytimes.in
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Re - Shreveport Times
Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today - Stocktwits
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - DelmarvaNow.com
Institutional scanner results for Telomir Pharmaceuticals Inc.2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
How to monitor Telomir Pharmaceuticals Inc. with trend dashboardsJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Why Is Telomir Pharmaceuticals Stock Trading Higher Today?Telomir Pharmaceuticals (NASDAQ:TELO) - Benzinga
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies - The Florida Times-Union
Telomir stock soars after drug shows promise against aggressive breast cancer - Investing.com
Telomir Pharma’s Cutting-Edge Cancer Breakthrough - StocksToTrade
Telomir’s Investigational Therapy: A Game Changer? - timothysykes.com
Pre-Market Titans: TTRX, BJDX & UPC Set The Pace - RTTNews
Telomir-1 shows promise against triple-negative breast cancer By Investing.com - Investing.com South Africa
Selective killing of aggressive TNBC cells: Telomir's Telomir‑1 disrupts iron-driven energy and mitochondrial function - Stock Titan
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - inkl
Weiss Ratings Reiterates “Sell (E+)” Rating for Telomir Pharmaceuticals (NASDAQ:TELO) - Defense World
Telomir Pharmaceuticals Telomir-1 selectively kills aggressive triple-negative breast cancer cells - MarketScreener
Telomir Pharmaceuticals Unveils Promising Cancer Treatment Discovery - TipRanks
Telomir shares surge after breakthrough tumor suppressor gene reactivation data - MSN
Telomir stock soars after tumor suppressor gene reactivation results - Investing.com
Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED) - Benzinga
Morning Market Movers: SPRB, LXEO, BMEA, Seeing Big Swings - RTTNews
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models - MarketScreener
Telomir-1 shows promise in reactivating tumor suppressor genes By Investing.com - Investing.com Nigeria
Telomir-1 shows promise in reactivating tumor suppressor genes - Investing.com
Telomir Telomir-1 Resets DNA Methylation of MASPIN, RASSF1A | TELO Stock News - Stock Titan
Telomir Pharmaceuticals Inc (TELO) 財務データ
収益
当期純利益
現金流量
EPS
1.11%
大文字化:
|
ボリューム (24 時間):